Innoviva
INVA
209 hedge funds and large institutions have $966M invested in Innoviva in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 27 closing their positions.
139% more call options, than puts
Call options by funds: $158K | Put options by funds: $66K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
7% more capital invested
Capital invested by funds: $903M → $966M (+$63.3M)
10% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 71
4% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 27
2% less funds holding
Funds holding: 214 → 209 (-5)
2.43% less ownership
Funds ownership: 111.55% → 109.12% (-2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.8M |
| 2 |
BlackRock
New York
|
+$4.45M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.56M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$3.25M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$14.7M |
| 2 |
Morgan Stanley
New York
|
-$7.73M |
| 3 |
Millennium Management
New York
|
-$4.86M |
| 4 |
Goldman Sachs
New York
|
-$4.66M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.75M |
INVA Hedge Fund Activity: Q4 2022 in Review
209 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2022, worth a combined $966M — up 7% from $903M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of INVA and 26 opened new positions — a net loss of 1 holder — while 71 trimmed existing stakes and 78 added.
The largest buyer was UBS Group, adding an estimated $5.8M. The largest seller was LSV Asset Management, cutting an estimated $14.7M.
- 209 institutional investors held Innoviva (INVA) as of Q4 2022, down from 214 in Q3 2022.
- Funds reported $966M of Innoviva stock for Q4 2022, up 7% quarter-over-quarter.
- 26 funds opened new Innoviva positions in Q4 2022 and 27 closed out, a net change of -1 holder.
- The largest Innoviva buyer in Q4 2022 was UBS Group, an estimated $5.8M added.
- The largest Innoviva seller in Q4 2022 was LSV Asset Management, an estimated $14.7M sold.
Based on aggregated 13F filings for Q4 2022.